missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Pexidartinib

Click to view available options
Quantité:
10 mg
50 mg
Conditionnement:
10mg
50mg
Description
Pexidartinib is a potent colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase inhibitor (IC50 = 20 nM). In the B16F10 mouse melanoma model, Pexidartinib reduces the systemic and local accumulation of macrophages without affecting Gr-1+ myeloid derived suppressor cells. When combined with tumor-specific CD8 T cell immunotherapy, Pexidartinib promotes the control of tumor growth. In the BRAFV600E-driven mouse melanoma model, Pexidartinib improves the efficacy of adoptive cell therapy with reduction of TIMs and an increase in tumor-infiltrating lymphocytes and T cells. Orally bioavailable.
Spécification
Spécification
| Nom chimique ou matériau | N-[5-[(5-Chloro-1 H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine |
| CAS | 1029044-16-3 |
| Quantité | 10 mg |
| Cible | Additional RTK Inhibitors |
| Formule moléculaire | C20H15ClF3N5 |
| Pureté | 98% |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu